Copaxone (glatiramer acetate injection), 20 mg/1 mL, 1 mL pre-filled syringe, packaged in 30 single-use PRE-FILLED Syringes and 33 Alcohol Preps (Swabs) per carton, Rx only, Marketed by: Teva Neuroscience, Inc., Kansas City, MO 64131; Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 68546-317-30, UPC 3 68546 31730 4.
Published November 27, 2013 · Recall initiated: October 24, 2013
Summary
FDA records drug Class II recall D-001-2014, published November 27, 2013 and initiated October 24, 2013. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 6,803 cartons; Lot: Lot X06381, Exp 10/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: A foreign particle found in a pre-filled syringe was reported through a consumer complaint about a pre-filled syringe.
What to do
Voluntary: Firm initiated · Letter
Get an email if COPAXONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- COPAXONE
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- Nationwide
- UPC
- 368546317304
- Lot
- Lot X06381, Exp 10/14
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAOxcarbazepine Oral Suspension, 300 mg/5 mL, 250 mL bottle, Rx only, Boehringer Ingelheim, Roxane Laboratories,November 27, 2013
- FDAAcetaminophen suspension liquid, 160 mg/5 mL, dye-free cherry flavor, co-packaged with an oral dosing syringeNovember 27, 2013
- FDAAccess 2 Immunoassay System, Part Number: 81600N The Access Immunoassay System is an in vitro diagnosticNovember 20, 2013
- FDAThe Plum A+ Infusion System is a cassette based multifunction infusion system that allows two lines in and oneNovember 20, 2013
- FDACopaxone (glatiramer acetate injection), 20 mg/1 mL, packaged in 30 single use PRE-FILLED syringes and 33April 24, 2013
- FDACopaxone (glatiramer acetate injection), 20mg/mL, 1 mL , Rx only, Marketed by: Teva Neuroscience - NDCAugust 15, 2012
Questions about this recall
Was Copaxone (glatiramer acetate injection), 20 mg/1 mL, 1 mL pre-filled syringe, packaged in 30 single-use PRE-FILLED Syringes and 33 Alcohol Preps (Swabs) per carton, Rx only, Marketed by: Teva Neuroscience, Inc., Kansas City, MO 64131; Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 68546-317-30, UPC 3 68546 31730 4. recalled?
Yes. FDA published recall D-001-2014 on November 27, 2013. Reported hazard: Presence of Particulate Matter: A foreign particle found in a pre-filled syringe was reported through a consumer complaint about a pre-filled syringe.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: COPAXONE. UPC: 368546317304.